News
PRESSEMITTEILUNGEN
Impulse Dynamics Receives Approval to Sell Optimizer CCM Devices in China
NEWS IMPULSE DYNAMICS RECEIVES APPROVAL TO SELL OPTIMIZER CCM DEVICES IN CHINA NMPA Clears the Way for Impulse Dynamics to Deliver Hope for Heart Failure Population MARLTON, N.J., February 22, 2021 — Impulse Dynamics, a company dedicated to improving the lives of...
Global Regulatory Organization Certifies Optimizer Smart Device as Compliant for Whole-Body MRI Scans in the EU
NEWS GLOBAL REGULATORY ORGANIZATION CERTIFIES OPTIMIZER SMART DEVICE AS COMPLIANT FOR WHOLE-BODY MRI SCANS IN THE EU Impulse Dynamics Receives Medical Device Approval for European Union to Safely Administer MRI Scans for Heart Failure Patients with Implanted Optimizer...
Impulse Dynamics Announces FDA Approval for Magnetic Resonance Imaging
NEWS IMPULSE DYNAMICS ANNOUNCES FDA APPROVAL FOR MAGNETICRESONANCE IMAGING FDA Clears Potential Hurdle for Many Heart Failure Patients MARLTON, N.J., January 20, 2021 — Impulse Dynamics, a company dedicated to improving the lives of people with heart failure (HF),...
Impulse Dynamics Closes $60 Million Financing
NEWS IMPULSE DYNAMICS CLOSES $60 MILLION FINANCING Funding to Accelerate Clinical and Product Development Pipelines, Commercialization of Optimizer Smart System for Heart Failure MARLTON, N.J., January 12, 2021 — Impulse Dynamics, a company dedicated to helping...
Impulse Dynamics Announces First Heart Failure Patient Treated with CCM Therapy in Brazil
NEWS Impulse Dynamics Announces First Heart Failure Patient Treated with CCM Therapy in Brazil Breakthrough Therapy Now Commercially Available in South America’s Most Populous Country MARLTON, N.J. – January 05, 2021 – Impulse Dynamics, a company dedicated to helping...
Impulse Dynamics Announces Publication of Data from FIX-HF-5C2 Study Evaluating the Two-Lead Optimizer System
NEWS Impulse Dynamics Announces Publication of Data from FIX-HF-5C2 Study Evaluating the Two-Lead Optimizer System Availability of the two-lead device represents a significant advancement in the development of cardiac contractility modulation therapy for patients with...
Impulse Dynamics Announces First Enrollment in Post-Approval Study of CCM Therapy Delivered by the Optimizer System
NEWS Impulse Dynamics Announces First Enrollment in Post-Approval Study of CCM Therapy Delivered by the Optimizer System Post-Approval Study will evaluate real-world safety and efficacy evidence for breakthrough heart failure therapy MOUNT LAUREL, N.J. – March 17,...
Impulse Dynamics Appoints Medical Director to Leadership Team
NEWS Impulse Dynamics Appoints Medical Director to Leadership Team Ishu Rao, M.D., brings wealth of clinical expertise during time of rapid company growth MOUNT LAUREL, N.J. – March 10, 2020 Impulse Dynamics, a company dedicated to improving the lives of people with...
IMPULSE DYNAMICS SECURES $80.25 MILLION FINANCING
NEWSIMPULSE DYNAMICS SECURES $80.25 MILLION FINANCINGFunding to Accelerate Commercialization of the Optimizer Smart System for Heart Failure MOUNT LAUREL, N.J. – December 3, 2019 – Impulse Dynamics, developer of Optimizer® Smart System for delivering CCM™ therapy,...
Impulse Dynamics Secures Transitional Pass-through (TPT) Incremental Payment for the Optimizer Smart System
NEWSImpulse Dynamics Secures Transitional Pass-through (TPT) Incremental Payment for the Optimizer Smart System2020 Payment Rules from the Centers for Medicare and Medicaid Services Bring CCM Therapy to Heart Failure Patients in the Outpatient Setting Mount Laurel,...
© 2021 Impulse Dynamics Nutzungsbedingungen | Datenschutz